STOP Pain Act

Hozzl · 2023-01-11T13:33:02Z

Explore the details of House Bill 5249 STOP Pain Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

1/11/2023, 1:33 PM

Congressional Summary of HR 5249

Safe Treatments and Opportunities to Prevent Pain Act or the STOP Pain Act

This bill authorizes the National Institutes of Health (NIH) to intensify and coordinate NIH research into the understanding of pain, therapies for chronic pain, and alternatives to opioids (drugs with effects similar to opium) for pain treatments.

The prioritization and direction of federally funded pain research must consider recommendations made by the Interagency Pain Research Coordinating Committee.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5249

Bill HR 5249 is currently in the status of Bill Introduced since May 16, 2016. Bill HR 5249 was introduced during Congress 114 and was introduced to the House on May 16, 2016. Bill HR 5249's most recent activity was Referred to the Subcommittee on Health. as of May 20, 2016

Bipartisan Support of Bill HR 5249

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5249

Primary Policy Focus

Health

Potential Impact Areas

- Drug therapy

- Drug trafficking and controlled substances

- Medical research

- Prescription drugs

- Research administration and funding

Alternate Title(s) of Bill HR 5249

STOP Pain Act

To direct the NIH to intensify and coordinate fundamental, translational, and clinical research with respect to the understanding of pain, the discovery and development of therapies for chronic pain, and the development of alternatives to opioids for effective pain treatments.

STOP Pain Act

Safe Treatments and Opportunities to Prevent Pain Act